Cargando…

Recombinant snake venom prothrombin activators

Three prothrombin activators; ecarin, which was originally isolated from the venom of the saw-scaled viper Echis carinatus, trocarin from the rough-scaled snake Tropidechis carinatus, and oscutarin from the Taipan snake Oxyuranus scutellatus, were expressed in mammalian cells with the purpose to obt...

Descripción completa

Detalles Bibliográficos
Autor principal: Lövgren, Ann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3669156/
https://www.ncbi.nlm.nih.gov/pubmed/23111318
http://dx.doi.org/10.4161/bioe.22676
_version_ 1782271707968438272
author Lövgren, Ann
author_facet Lövgren, Ann
author_sort Lövgren, Ann
collection PubMed
description Three prothrombin activators; ecarin, which was originally isolated from the venom of the saw-scaled viper Echis carinatus, trocarin from the rough-scaled snake Tropidechis carinatus, and oscutarin from the Taipan snake Oxyuranus scutellatus, were expressed in mammalian cells with the purpose to obtain recombinant prothrombin activators that could be used to convert prothrombin to thrombin. We have previously reported that recombinant ecarin can efficiently generate thrombin without the need for additional cofactors, but does not discriminate non-carboxylated prothrombin from biologically active γ-carboxylated prothrombin. Here we report that recombinant trocarin and oscutarin could not efficiently generate thrombin without additional protein co-factors. We confirm that both trocarin and oscutarin are similar to human coagulation Factor X (FX), explaining the need for additional cofactors. Sequencing of a genomic fragment containing 7 out of the 8 exons coding for oscutarin further confirmed the similarity to human FX.
format Online
Article
Text
id pubmed-3669156
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Landes Bioscience
record_format MEDLINE/PubMed
spelling pubmed-36691562013-06-04 Recombinant snake venom prothrombin activators Lövgren, Ann Bioengineered Research Note Three prothrombin activators; ecarin, which was originally isolated from the venom of the saw-scaled viper Echis carinatus, trocarin from the rough-scaled snake Tropidechis carinatus, and oscutarin from the Taipan snake Oxyuranus scutellatus, were expressed in mammalian cells with the purpose to obtain recombinant prothrombin activators that could be used to convert prothrombin to thrombin. We have previously reported that recombinant ecarin can efficiently generate thrombin without the need for additional cofactors, but does not discriminate non-carboxylated prothrombin from biologically active γ-carboxylated prothrombin. Here we report that recombinant trocarin and oscutarin could not efficiently generate thrombin without additional protein co-factors. We confirm that both trocarin and oscutarin are similar to human coagulation Factor X (FX), explaining the need for additional cofactors. Sequencing of a genomic fragment containing 7 out of the 8 exons coding for oscutarin further confirmed the similarity to human FX. Landes Bioscience 2013-05-01 2012-10-30 /pmc/articles/PMC3669156/ /pubmed/23111318 http://dx.doi.org/10.4161/bioe.22676 Text en Copyright © 2013 Landes Bioscience http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.
spellingShingle Research Note
Lövgren, Ann
Recombinant snake venom prothrombin activators
title Recombinant snake venom prothrombin activators
title_full Recombinant snake venom prothrombin activators
title_fullStr Recombinant snake venom prothrombin activators
title_full_unstemmed Recombinant snake venom prothrombin activators
title_short Recombinant snake venom prothrombin activators
title_sort recombinant snake venom prothrombin activators
topic Research Note
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3669156/
https://www.ncbi.nlm.nih.gov/pubmed/23111318
http://dx.doi.org/10.4161/bioe.22676
work_keys_str_mv AT lovgrenann recombinantsnakevenomprothrombinactivators